Louisiana State Employees Retirement System’s Vanda Pharmaceuticals VNDA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
– Sell
-30,100
Closed -$198K – 1541
2023
Q2
$198K Buy
30,100
+3,600
+14% +$23.1K ﹤0.01% 1506
2023
Q1
$180K Sell
26,500
-400
-1% -$2.81K ﹤0.01% 1485
2022
Q4
$199K Sell
26,900
-100
-0.4% -$974 0.01% 1478
2022
Q3
$267K Sell
27,000
-300
-1% -$3.17K 0.01% 1410
2022
Q2
$315K Buy
27,300
+200
+0.7% +$2.07K 0.01% 1392
2022
Q1
$305K Buy
27,100
+100
+0.4% +$1.31K 0.01% 1436
2021
Q4
$424K Buy
27,000
+200
+0.7% +$3.48K 0.01% 1368
2021
Q3
$459K Buy
26,800
+1,700
+7% +$29.8K 0.01% 1332
2021
Q2
$540K Buy
25,100
+200
+0.8% +$3.58K 0.01% 1248
2021
Q1
$374K Sell
24,900
-300
-1% -$4.86K 0.01% 1378
2020
Q4
$331K Sell
25,200
-100
-0.4% -$1.2K 0.01% 1348
2020
Q3
$244K Buy
25,300
+10,570
+72% +$113K 0.01% 1310
2020
Q2
$169K Hold
14,730
– – 0.01% 1251
2020
Q1
$153K Sell
14,730
-3,540
-19% -$43.9K 0.01% 1163
2019
Q4
$300K Sell
18,270
-1,430
-7% -$21.6K 0.01% 1238
2019
Q3
$262K Hold
19,700
– – 0.01% 1276
2019
Q2
$269K Hold
19,700
– – 0.01% 1281
2019
Q1
$362K Buy
19,700
+26
+0.1% +$592 0.02% 1186
2018
Q4
$514K Sell
19,674
-3,526
-15% -$82.9K 0.03% 908
2018
Q3
$532K Buy
+23,200
New +$474K 0.02% 1118

Other funds holding VNDA

Louisiana State Employees Retirement System's VNDA Position: Q3 2023 in Review

Louisiana State Employees Retirement System sold out of Vanda Pharmaceuticals (VNDA) in Q3 2023, closing a stake of 30,100 shares — an estimated $198K sold.

Louisiana State Employees Retirement System first reported a position in VNDA in Q3 2018 and held it in 20 quarters. The position peaked at $540K in Q2 2021. 179 funds tracked by Wall St. Rank hold VNDA as of Q3 2023.

  • Louisiana State Employees Retirement System reported no remaining Vanda Pharmaceuticals position as of Q3 2023 after selling out during the quarter.
  • Louisiana State Employees Retirement System sold 30,100 Vanda Pharmaceuticals shares in Q3 2023, an estimated $198K.
  • Louisiana State Employees Retirement System first reported a position in Vanda Pharmaceuticals in Q3 2018 and held it in 20 quarters.
  • Louisiana State Employees Retirement System's Vanda Pharmaceuticals position peaked at $540K in Q2 2021.
  • 179 funds tracked by Wall St. Rank held Vanda Pharmaceuticals as of Q3 2023.

Based on Louisiana State Employees Retirement System's 13F filing for Q3 2023, filed 17 Oct 2023.